{"name":"Mandos LLC","slug":"mandos-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxOVG1uanhmM2NkOGlxTFhhUHVfdGpESm5vc1I4QXJTMWl3VTduRWItaUtNZmFHdWhUUDdFd1l0bXFZMng3V191VkxsWGJMV1JNV1pELXFhYUNrZ2I5elJxN1FBRFJvR0ZhcHRfYlJmWm1OWG9lU1hRN2E0cnBPb3RkZm5uYm1oc0x6VzJfcXd0Szd0b3BjdU1rU2pheHdwZGVsMXFQdVJSM0YtOHZCTlAwZ21TVXZTblRQVUFwQ1czeXo0aVNQV1ZPdXI2RGMwS3JwempOUVFFcnpERV83ZXNiUXpOYWNBdUllNG9sak5PcEJHNUo0RU9yd2oycU5oRXhfS3dSak1YY0hOWUd4b0w5aWxQOHBiaEpMek9V?oc=5","date":"2026-02-23","type":"regulatory","source":"businesswire.com","summary":"Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C - businesswire.com","headline":"Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNajQ1UkNnTDdlbC13TTIzZEFqT0NKMWlNdVlMd2JtUkw2UElVVk9wYlhLUFE1eDF3QkdQN3k3azJRQ1RlYUYzQ3l2SldXMmFHWTZBVDh1dkw0ZnJSdDlSRXprczkwT2tEVjd5OEQ1eGUtSDhobE9jMzcwVWFjeWhzTGlrRS1tM09qUWpQbTJ3ZDB5VFZvRFc1NGZCam9EMmg0NDBTTmtiWmItZUVYUlpQUmIwZXZObER3bWlFeS13VDIzTk9pVmp2U1BmLWdtLUVOQU90X2hDM3lVVXl6QkI3ZA?oc=5","date":"2025-12-19","type":"regulatory","source":"PharmiWeb.com","summary":"Beren, Through its Subsidiary Mandos, Submits New Drug Application to U.S. FDA for Adrabetadex in In - PharmiWeb.com","headline":"Beren, Through its Subsidiary Mandos, Submits New Drug Application to U.S. FDA for Adrabetadex in In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOZ09hZnFzTTMwX0FYclpyOWhWR3hqQzRhcGgzdXRBVC1EY0xob0RJcHdvQkZFQ25xeXRRSlpUdkxxZEhxSmhPcjVQRUdaLWlvMmtrcnh6eHlBc1JBWmVhbGs4bmN5cjV6SHd0WjRKUHlNWk9Sc1RVLTI3UHp4eTBDdjQzNmVXd0xJLUgwUVdndllKOW1TLWhmUlYxZmJUQ0p1VjM5TlVZQ29xdlA0RDhhZDh0c1A3QW5kQU1RcktISnR3VTVtaTZya2xWSFZ3bmkyT0YwVlJ1SXFOcHdJSzVqaWZoR012ajBBM3RGSWwzdXY4V2hBa0RtU0ZQNklSblNLMnZvR0lpUFB6MXAycXBiM2dB?oc=5","date":"2025-12-10","type":"regulatory","source":"BioSpace","summary":"FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Niemann-Pick Disease Type C - BioSpace","headline":"FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Nie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQTkpfXzA4T2VaNmVWeUg0SHpLQmJZbGVzTzRJYVpWbTd3ZDZ5eVdFUEtnQ25YYjNyMmhTTm9iYm5idjFRNDVsaWlkZ1lqeGdWcWJUMDUtMHk4ZHhJRkp5N1JnNmpPMFJ1ZWI4NjM2NzNLMUk4QmFweXVyaWljLVVDRjVsdnJ3SlVoWnhVUlp4TlBabFRqcFNrQ2ZDVEoxbkN4UHZ1dmhuNThQdDIyajk2eUx3V3dhZ0hxXzhQZldaS3BkVC1QdzhVSV94STF4T1pMSmRZSW5lNkJ2S1JsR2I5M2tLdEg0RW1fT05vSW0wUnVzeUZzS0xkbFdJOExuR1laYllFaU9mNjA0dUdueWxucklaaHNacXhMaFVMTmd3WQ?oc=5","date":"2025-10-09","type":"regulatory","source":"businesswire.com","summary":"Data Analyses Show Benefit for Individuals With Infantile-Onset Niemann-Pick Disease Type C Treated With Investigational Drug Adrabetadex - businesswire.com","headline":"Data Analyses Show Benefit for Individuals With Infantile-Onset Niemann-Pick Disease Type C Treated With Investigational","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOV3RWYUJVRXJIM0lCU2hnUDRGZzF4bm56bE1Rc2d1a3djT0dBanE3STh1ZmlnUnBTb0NWS0VJbEtvaGYzMWZLNnd1UFBzZ216UGlqTXZtWXdwZ0JMWC1QenBrMmlNTXZTeTJqTTllWWRXd1duUm43UFZfc0JnYTFiTUdvdkRBRjN0SmFjZ2g0b2tKbk5ScjBvcFRfSGhmcW8tSTctR3oxOXFscXpKektRQ0VGUHRnQ1lJTE9pQTNOVE1ZZkhobkVJazRHb1lCV2FEX09MR2gweTBoNUVZdWFVNlltRFZ0NWpxekpBcjVqbHdjMkVVaFRWSGluRGpKaTd0UXI5LUFWc2oxVTNiN3ctSW1lSlk?oc=5","date":"2025-09-12","type":"regulatory","source":"businesswire.com","summary":"Mandos Health to Present New Analyses in Niemann-Pick Disease Type C at the 2025 American Neurological Association Annual Meeting - businesswire.com","headline":"Mandos Health to Present New Analyses in Niemann-Pick Disease Type C at the 2025 American Neurological Association Annua","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-09-19","type":"regulatory","source":"prnewswire.com","summary":"Niemann-Pick Disease Type C Market to Proliferate by 2032, Predicts DelveInsight | Key Companies in the Market - Azafaros A.G., Cyclo Therapeutics, Inc., ZevraDenmark, Genzyme, IntraBio Inc, Mandos He","headline":"Niemann-Pick Disease Type C Market to Proliferate by 2032, Predicts DelveInsight | Key Companies in the Market - Azafaro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNY1hBVmItbVdRd0ZEVHVsSmhyRWRkdWVMQUppcWRlRTg0NmJqVjRnSHp3MmpFSXhRYzRfNGJoaVplM0pDcG5FRVJwYTdEMUkwZ3ctNG5YZ0NaUm81TWhGRlBoQkJKdWxWSXg1cHZZd3ZsRlBiN0h5Rm9sM3NJMDVCZU9EZmZGUkNCeW84N2U0ZkdvaVFHYkZtMnBrY1h2cks0bVQtYmNJMUZ3em1UMDR4eEh0RDA1UFZXXzZOeV9DQzlteXBlM0ZBMA?oc=5","date":"2021-08-23","type":"regulatory","source":"ABC15 Arizona","summary":"Valley baby showing great progress with experimental Niemann-Pick Type C disease drug treatments - ABC15 Arizona","headline":"Valley baby showing great progress with experimental Niemann-Pick Type C disease drug treatments - ABC15 Arizona","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPbTFZRFk5RGppVkNlSF8wNUF4UHQ4QkJEdUo5a3plQ2R3c19MRjM3VlRIVWhvQWF6eEttcXNkeTBSZGJaMVdLWlhHaXdqMjB3dGh0YVdVNjhLcURzY0ktYm5CMTNFOTNmZzRqUzhjQXk3N29hdGg3SVBJZlNYcmtzbER5SjNEMTJqN0JIMzRrZzg1NzhQSzdr?oc=5","date":"2021-05-20","type":"pipeline","source":"statnews.com","summary":"'There's so much uncertainty': As Mallinckrodt sells rare disease drug, parents worry about access - statnews.com","headline":"'There's so much uncertainty': As Mallinckrodt sells rare disease drug, parents worry about access","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}